RU2019103805A3 - - Google Patents

Download PDF

Info

Publication number
RU2019103805A3
RU2019103805A3 RU2019103805A RU2019103805A RU2019103805A3 RU 2019103805 A3 RU2019103805 A3 RU 2019103805A3 RU 2019103805 A RU2019103805 A RU 2019103805A RU 2019103805 A RU2019103805 A RU 2019103805A RU 2019103805 A3 RU2019103805 A3 RU 2019103805A3
Authority
RU
Russia
Application number
RU2019103805A
Other versions
RU2756052C2 (ru
RU2019103805A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019103805A publication Critical patent/RU2019103805A/ru
Publication of RU2019103805A3 publication Critical patent/RU2019103805A3/ru
Application granted granted Critical
Publication of RU2756052C2 publication Critical patent/RU2756052C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/4045Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401Proline; Derivatives thereof, e.g. captopril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2019103805A 2016-08-16 2017-08-16 Модифицированные пептиды для применения при лечении нейродегенеративных заболеваний RU2756052C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1613999.0 2016-08-16
GBGB1613999.0A GB201613999D0 (en) 2016-08-16 2016-08-16 Neurodegenerative disorders
GB1701455.6 2017-01-30
GBGB1701455.6A GB201701455D0 (en) 2016-08-16 2017-01-30 Neurodegenerative disorders
PCT/GB2017/052407 WO2018033724A1 (en) 2016-08-16 2017-08-16 Modified peptides for use in treating neurodegenerative disorders

Publications (3)

Publication Number Publication Date
RU2019103805A RU2019103805A (ru) 2020-09-21
RU2019103805A3 true RU2019103805A3 (ru) 2020-10-30
RU2756052C2 RU2756052C2 (ru) 2021-09-24

Family

ID=56985964

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019103805A RU2756052C2 (ru) 2016-08-16 2017-08-16 Модифицированные пептиды для применения при лечении нейродегенеративных заболеваний

Country Status (13)

Country Link
US (1) US11939398B2 (ru)
EP (1) EP3500252B1 (ru)
JP (1) JP7125143B2 (ru)
KR (1) KR102457935B1 (ru)
CN (1) CN109640972B (ru)
AU (1) AU2017313372B2 (ru)
BR (1) BR112019003189A2 (ru)
CA (1) CA3033497A1 (ru)
ES (1) ES2930320T3 (ru)
GB (2) GB201613999D0 (ru)
MX (1) MX2019001804A (ru)
RU (1) RU2756052C2 (ru)
WO (1) WO2018033724A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201613999D0 (en) 2016-08-16 2016-09-28 Neuro-Bio Ltd Neurodegenerative disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013633A (en) * 1997-08-07 2000-01-11 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
US6126939A (en) 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
IL146009A0 (en) 1999-05-05 2002-07-25 Neurochem Inc Stereoselective antifibrillogenic peptides and peptidomimetics thereof
RU2002102868A (ru) 1999-08-09 2004-01-27 Трипеп Аб (Se) Ингибиторы полимеризации белка и способы их использования
AU2001289160A1 (en) 2000-08-24 2002-03-04 Neuronz Ltd. Gpe analogs
CN1535264A (zh) 2001-05-15 2004-10-06 ������ҩ��ʽ���� 精氨酸衍生物
JP2004155695A (ja) * 2002-11-06 2004-06-03 Taisho Pharmaceut Co Ltd Mc4受容体に対するリガンド
US20050159362A1 (en) 2003-04-22 2005-07-21 Sircar Jagadish C. Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
AU2004251522C1 (en) 2003-06-30 2011-12-15 Tel Aviv University Future Technology Development L.P. Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
JP2006347951A (ja) 2005-06-16 2006-12-28 Yoshihiro Futamura 神経細胞活性化作用を有するトリペプチド、それからなる食品製剤、化粧品及び抗認知症剤
GB2432586B (en) * 2005-11-25 2010-01-13 Univ Open Treatment of neurodegenerative disorders
ES2686820T3 (es) 2012-01-03 2018-10-22 Neostrata Company, Inc. Derivados de N-acilpéptido y sus usos
GB2516045A (en) * 2013-07-09 2015-01-14 Neuro Bio Ltd Neurodegenerative disorders
GB201613999D0 (en) 2016-08-16 2016-09-28 Neuro-Bio Ltd Neurodegenerative disorders

Also Published As

Publication number Publication date
CN109640972A (zh) 2019-04-16
RU2756052C2 (ru) 2021-09-24
ES2930320T3 (es) 2022-12-09
EP3500252B1 (en) 2022-11-02
US11939398B2 (en) 2024-03-26
AU2017313372B2 (en) 2022-12-22
MX2019001804A (es) 2019-07-01
GB201701455D0 (en) 2017-03-15
CN109640972B (zh) 2023-05-26
US20210094983A1 (en) 2021-04-01
JP2019532028A (ja) 2019-11-07
JP7125143B2 (ja) 2022-08-24
KR102457935B1 (ko) 2022-10-21
CA3033497A1 (en) 2018-02-22
BR112019003189A2 (pt) 2019-11-26
AU2017313372A1 (en) 2019-03-07
WO2018033724A1 (en) 2018-02-22
KR20190039271A (ko) 2019-04-10
EP3500252A1 (en) 2019-06-26
GB201613999D0 (en) 2016-09-28
RU2019103805A (ru) 2020-09-21

Similar Documents

Publication Publication Date Title
BR112019001695A2 (ru)
IN201641011101A (ru)
BR122021026889A2 (ru)
RU2019103805A3 (ru)
BR112019009269A2 (ru)
BR202016021748U2 (ru)
CN303540162S (ru)
CN303540820S (ru)
CN303549390S (ru)
CN303550990S (ru)
CN303553143S (ru)
CN303561212S (ru)
CN303564280S (ru)
CN303564770S (ru)
CN303564847S (ru)
CN303566532S (ru)
CN303569414S (ru)
CN303570134S (ru)
CN303572222S (ru)
CN303572648S (ru)
CN303572859S (ru)
CN303578830S (ru)
CN303584333S (ru)
CN303587513S (ru)
CN303589377S (ru)